Boston Scientific Stock Drops Amid Weak Demand, Leidos and Insulet Also in Focus
Boston Scientific stock fell after the company reiterated underwhelming full-year growth guidance. Leidos and Insulet also had recent news, with Leidos facing increased demand in the defense technology sector and Insulet stock dropping 5.1%.
Boston Scientific shares plummeted after the company reaffirmed subdued growth expectations for the year, citing weak demand. This led to a 12% single-day stock price drop for the medical device maker.
Leidos Holdings, on the other hand, continues to ride steady defense technology demand. Analysts have even cut the stock's 12-month price target, indicating 40% upside potential.
In related news, Insulet Corp's stock price dropped 5.1%, raising questions about the company's future prospects. Given the uncertain market dynamics, traders may find it useful to gauge when companies such as Boston Scientific, Leidos, or Insulet might be undervalued.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis